Document is current
Any future updates will be listed below
-
Authors
Miki, Atsuya
Kumoi, Miho
Maeda, Naoyuki
Koh, Shizuka
Matsushita, Kenji
Nishida, Kohji
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (10840)
- License Information
-
More Information
Article History
Received: 18 June 2019
Accepted: 27 December 2019
First Online: 13 February 2020
Conflicts of interest
: A. Miki, Consultant fee (Sensimed AG), Speaker fee (SEED, Santen, Pfizer Japan, Kowa, Otsuka, Alcon Japan, Topcon, Novartis, Hoya, Ellex, JFC Sales Plan, Senju); M. Kumoi, None; N. Maeda, Grant (Topcon), Lecture fee (Alcon, AMO); S. Koh, Grant (Johnson & Johnson, SEED, Shire), Lecture fee (Alcon Pharma, Johnson & Johnson, SEED, Oculus, Otsuka, Santen); K. Matsushita, Lecture fee (Alcon Japan, Alcon Pharma, Kowa, Nitten, Novartis, Otsuka, Pfizer Japan, Santen, Senju); K. Nishida, Grant (Otsuka, AMO, Topcon, Menicon, Wakamoto, Senju, Rhoto, Santen, Novartis, Alcon Japan, Pfizer Japan, Hoya, Bayer Yakuhin, MSD Japan, Kowa), Lecture fee (Novartis, Alcon Japan, Pfizer Japan, Hoya, Bayer Yakuhin, Kowa, Boehringer Ingelheim Japan, SEED, Chuo Sangio, Johnson & Johnson Japan).
